tiprankstipranks
Trending News
More News >
Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4
Germany Market

Vicore Pharma Holding AB (6Y4) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
4Neutral
12Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Vicore Pharma Holding AB’s (6Y4) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Vicore Pharma Holding AB is a Buy.
Vicore Pharma Holding AB’s (6Y4) 20-Day exponential moving average is 0.99, while Vicore Pharma Holding AB’s (6Y4) share price is €0.92, making it a Sell.
Vicore Pharma Holding AB’s (6Y4) 50-Day exponential moving average is 0.99, while Vicore Pharma Holding AB’s (6Y4) share price is €0.92, making it a Sell.

Vicore Pharma Holding AB (6Y4) Pivot Points

Feb 18, 2026, 06:43 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.97
0.97
0.97
0.97
0.97
0.97
0.97
Fibonacci
0.97
0.97
0.97
0.97
0.97
0.97
0.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vicore Pharma Holding AB (6Y4) Moving Averages

Feb 18, 2026, 06:43 PM
Period
Simple
Exponential
MA5
0.95Sell
0.95Sell
MA10
0.96Sell
0.97Sell
MA20
1.01Sell
0.99Sell
MA50
0.98Sell
0.99Sell
MA100
0.99Sell
0.97Sell
MA200
0.91Buy
0.89Buy
Vicore Pharma Holding AB’s (6Y4) 10-Day exponential moving average is 0.97, while Vicore Pharma Holding AB’s (6Y4) share price is €0.92, making it a Sell.
Vicore Pharma Holding AB’s (6Y4) 100-Day exponential moving average is 0.97, while Vicore Pharma Holding AB’s (6Y4) share price is €0.92, making it a Sell.
Vicore Pharma Holding AB’s (6Y4) stock price is €0.92 and Vicore Pharma Holding AB’s (6Y4) 50-day simple moving average is 0.98, creating a Sell signal.
Vicore Pharma Holding AB’s (6Y4) stock price is €0.92 and Vicore Pharma Holding AB’s (6Y4) 100-day simple moving average is 0.99, creating a Sell signal.
Vicore Pharma Holding AB’s (6Y4) stock price is €0.92 and Vicore Pharma Holding AB’s (6Y4) 200-day simple moving average is 0.91, creating a Buy signal.

Vicore Pharma Holding AB (6Y4) Technical Indicators

Feb 18, 2026, 06:43 PM
Name
Value
Implied Action
RSI (14)
41.02
Neutral
STOCH (9,6)
40.27
Neutral
STOCHRSI (14)
18.52
Buy
MACD (12,26)
-0.02
Buy
ADX (14)
14.96
Buy
Williams %R
-95.37
Buy
CCI (14)
-96.57
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
31.37
Neutral
ROC
-18.42
Sell
Vicore Pharma Holding AB’s (6Y4) Relative Strength Index (RSI) is 41.02, creating a Neutral signal.
Vicore Pharma Holding AB’s (6Y4) Trend Strength Indicator (ADX) is 14.96, creating a Buy signal.
Vicore Pharma Holding AB’s (6Y4) Commodity Channel Index (CCI) is -96.57, creating a Neutral signal.
Vicore Pharma Holding AB’s (6Y4) Price Rate of Change (ROC) is -18.42, creating a Sell signal.

FAQ

Is 6Y4 a Buy, Hold, or Sell?
Based on 6Y4’s technical indicators, 6Y4 is a Sell.
    What is 6Y4’s RSI (14)?
    6Y4’s RSI (14) is 41.02, which suggests 6Y4 is a Neutral.
      What is 6Y4’s MACD?
      6Y4’s MACD is -0.02, which suggests 6Y4 is a Buy.
        What is 6Y4’s 5-day moving average?
        6Y4’s 5-day moving average is 0.95, which suggests 6Y4 is a Sell.
          What is 6Y4’s 20-day moving average?
          6Y4 20-day moving average is 1.01, which suggests 6Y4 is a Sell.
            What is 6Y4’s 50-day moving average?
            6Y4’s 50-day moving average is 0.98, which suggests 6Y4 is a Sell.
              What is 6Y4’s 200-day moving average?
              6Y4’s 200-day moving average is 0.91, which suggests 6Y4 is a Buy.
                What is 6Y4’s Williams % R (14)?
                6Y4’s Williams % R (14) is -95.37, which suggests 6Y4 is a Buy.
                  What is 6Y4’s CCI (14)?
                  6Y4’s CCI (14) is -96.57, which suggests 6Y4 is a Neutral.
                    What is the share price of Vicore Pharma Holding AB?